Moderna had designs on releasing a combined influenza and covid-19 vaccine after some promising trials, but this week the ...

After discussions with the FDA, Moderna has withdrawn its application for a combination shot, which had demonstrated efficacy ...

Since 2023, federal health officials have recommended an annual COVID-19 shot for most people, and vaccine makers have not ...

The vaccine is expected to be commercially ready for the 2025-2026 COVID-19 season. The Food and Drug Administration (FDA) has approved Nuvaxovid ™ (COVID-19 Vaccine, Adjuvanted) for active ...

At FDA, full vaccine approval is the gold standard. The agency was on track to sign off on Novavax’s license by its April 1 target date, according to two people with direct knowledge of the situation ...

The FDA has approved two fast tests for the coronavirus that is causing the COVID-19 epidemic, which are able to produce results within hours instead of days. Testing for the SARS-CoV-2 ...

Moderna conducted a study to test a combination COVID-19 and flu shot. Researchers tested the shot on 8,000 ... from the ...